Varex Imaging (NASDAQ:VREX) Releases Earnings Results, Beats Expectations By $0.19 EPS

Varex Imaging (NASDAQ:VREX) announced its quarterly earnings data on Tuesday. The company reported $0.37 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.18 by $0.19, Zacks reports. The company had revenue of $228.90 million for the quarter, compared to analysts’ expectations of $219.26 million. Varex Imaging had a positive return on equity of 5.54% and a negative net margin of 16.13%. Varex Imaging updated its Q1 2026 guidance to 0.050-0.250 EPS.

Varex Imaging Stock Performance

Shares of VREX traded up $0.43 during trading hours on Tuesday, reaching $11.86. 881,082 shares of the company traded hands, compared to its average volume of 424,557. The company has a quick ratio of 1.82, a current ratio of 3.51 and a debt-to-equity ratio of 0.78. The business has a fifty day moving average price of $11.83 and a 200-day moving average price of $9.82. Varex Imaging has a 12-month low of $6.76 and a 12-month high of $16.93. The stock has a market capitalization of $492.19 million, a P/E ratio of -3.69 and a beta of 0.98.

Hedge Funds Weigh In On Varex Imaging

A number of large investors have recently bought and sold shares of VREX. Quarry LP purchased a new position in Varex Imaging during the third quarter worth approximately $64,000. BNP Paribas Financial Markets lifted its position in shares of Varex Imaging by 18.5% during the 2nd quarter. BNP Paribas Financial Markets now owns 13,045 shares of the company’s stock valued at $113,000 after buying an additional 2,036 shares in the last quarter. Aquatic Capital Management LLC acquired a new stake in Varex Imaging in the 3rd quarter valued at $117,000. Cerity Partners LLC purchased a new stake in Varex Imaging in the 2nd quarter worth $123,000. Finally, The Manufacturers Life Insurance Company raised its position in Varex Imaging by 10.4% during the second quarter. The Manufacturers Life Insurance Company now owns 15,302 shares of the company’s stock worth $133,000 after acquiring an additional 1,442 shares during the period.

Wall Street Analysts Forecast Growth

A number of research firms have commented on VREX. Weiss Ratings reissued a “sell (d)” rating on shares of Varex Imaging in a research report on Wednesday, October 8th. Wall Street Zen cut Varex Imaging from a “strong-buy” rating to a “buy” rating in a research note on Saturday, August 9th. Finally, B. Riley reaffirmed a “buy” rating and set a $16.00 price objective (up previously from $12.00) on shares of Varex Imaging in a research report on Friday, August 8th. Two equities research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $19.50.

Varex Imaging Company Profile

Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers.